ECDC country visit to Norway to discuss antimicrobial resistance issues

Mission report
Cite:
Citation Link

European Centre for Disease Prevention and Control. ECDC country visit to Norway to discuss
antimicrobial issues 12–16 March 2018. Stockholm: ECDC; 2019.

Copy citation to clipboard

An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.

Executive summary

Data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show that the proportion of AMR in bacteria from bloodstream infections in Norwegian patients is consistently below the EU/EEA average and often among the lowest in Europe. Nevertheless, although considerably below the EU/EEA average, resistance to broad-spectrum antibiotics such as third-generation cephalosporins has been increasing over the past 10 years. This is the result of  emergence of strains that produce an extended-spectrum beta-lactamase (ESBL), combined with increasing consumption of broad-spectrum antibiotics in healthcare.

All updates on antimicrobial resistance and consumption

Publication

External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019

External quality assessment -

Event

Averting antimicrobial resistance: why leadership matters – ECDC session at the 16th World Congress on Public Health

13 Oct 2020

Publication

Gonococcal antimicrobial susceptibility surveillance in Europe, 2018

Surveillance report -

Publication

Country visit to Ireland to discuss policies relating to antimicrobial resistance

Mission report -

Data

EARS-Net Reporting protocol 2020

Tool -